VECTRX Trademark

Trademark Overview

On Friday, July 2, 2021, a trademark application was filed for VECTRX with the United States Patent and Trademark Office. The USPTO has given the VECTRX trademark a serial number of 90808859. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 29, 2024. This trademark is owned by NeoTherma Oncology, Inc.. The VECTRX trademark is filed in the Medical Instrument Products category with the following description:

Medical device for treating cancer; Medical device for improving the effectiveness of chemotherapy drugs and radiation therapy
vectrx

General Information

Serial Number90808859
Word MarkVECTRX
Filing DateFriday, July 2, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2022

Trademark Statements

Goods and ServicesMedical device for treating cancer; Medical device for improving the effectiveness of chemotherapy drugs and radiation therapy

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, September 14, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeoTherma Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWichita, KS 67203
Party NameNeoTherma Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWichita, KS 67201

Trademark Events

Event DateEvent Description
Tuesday, July 6, 2021NEW APPLICATION ENTERED
Tuesday, September 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 23, 2022ASSIGNED TO EXAMINER
Monday, March 28, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, March 28, 2022EXAMINERS AMENDMENT E-MAILED
Monday, March 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 28, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 28, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, April 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 3, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 3, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 7, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 7, 2022SOU EXTENSION 1 FILED
Wednesday, December 7, 2022SOU EXTENSION 1 GRANTED
Friday, December 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 8, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 8, 2023SOU EXTENSION 2 FILED
Thursday, June 8, 2023SOU EXTENSION 2 GRANTED
Saturday, June 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, December 18, 2023SOU EXTENSION 3 FILED
Monday, December 18, 2023SOU EXTENSION 3 GRANTED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 29, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 29, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

vectrx medical device drugs therapy chemotherapy radiation improving treating cancer effectiveness